Abstract

Case Report

First trimester growth delay: An early marker of triploidy

Sydney M Thayer*, Rachel A Pilliod, Emmanuelle Pare, Amber Vandehey, Hannah Raszka, Kelly Thomas and Rinathia Hachmon

Published: 21 November, 2019 | Volume 2 - Issue 2 | Pages: 119-121

Triploidy is one the most common chromosomal abnormality in humans, complicating about 1% of all human pregnancies. Most affected conceptions undergo spontaneous abortion in the first trimester, making the prevalence of second trimester triploidy low. Viable triploidy is associated with high rates of maternal morbidity, including hypertensive disorders, hemorrhage, and persistent trophoblasic disease, as well as fetal and neonatal severe adverse outcomes. Given these complications, early identification of triploidy in ongoing pregnancies may inform patient counseling and management.

Read Full Article HTML DOI: 10.29328/journal.cjog.1001032 Cite this Article Read Full Article PDF

References

  1. Kuhn P, de Lourdes Brizot M, Pandya PP, Snijder RJ, Nicholaides KH. Crown-rump length in chromosomally abnormal fetuses at 10 to 13 weeks’ gestation. Am J Obstet Gynecol. 1995; 172: 32-35. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/7847557
  2. Pircon RA, Porto M, Towers CV, Crade M, Gocke SE. Ultrasound Findings in Pregnancies Complicated by Fetal Triploidy. J Ultrasound Med. 1989; 8: 507-511. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/2674473
  3. Crane JP, Beaver HA, Cheung SW. Antenatal Ultrasound Findings in Fetal Triploidy Syndrome. J Ultrasound Med. 1985; 4: 519-524. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/3903185
  4. Pandya PP, Kondylois A, Hilbert L, Snijders RJ, Nicholaides KH. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol. 1995; 5: 15-19. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/7850583
  5. Spencer K, Liao AW, Skentou H, Cicero S, Nicolaides KH. Screening for triploidy by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagno. 2000; 20: 495-499. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10861716
  6. Salomon LJ, Bernard JP, Nizard J, Ville Y. First-trimester screening for fetal triploidy at 11 to 14 weeks: a role for fetal biometry. Prenat Diagn. 2005; 25: 479-483. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15966039
  7. Jauniaux E, Brown R, Rodeck C, Nicolaides KH. Prenatal diagnosis of triploidy during the second trimester of pregnancy. Obstet Gynecol. 1996; 88: 983-989. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/8942839
  8. Benacerraf BR. Intrauterine Growth Retardation in the First Trimester Associated with Triploidy. J Ultrasound Med. 1988; 7: 153-154. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/3280825

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Similar Articles

Recently Viewed

  • Correlation of plasma protein from MDS, young and elderly patients by SDS-page
    Nathanielly de Lima Silva*, Josiel Nascimento dos Santos, Márcia Santos Rezende, Lúcio Henrique Sousa Pinheiro, Carlos Arthur Cardoso Almeida, Dulce Marta Schimieguel and Danilo Nobre Nathanielly de Lima Silva*,Josiel Nascimento dos Santos,Márcia Santos Rezende,Lúcio Henrique Sousa Pinheiro,Carlos Arthur Cardoso Almeida,Dulce Marta Schimieguel,Danilo Nobre. Correlation of plasma protein from MDS, young and elderly patients by SDS-page. Int J Bone Marrow Res. 2019: doi: 10.29328/journal.ijbmr.1001009; 2: 087-088
  • Drug abuse and its ramifications on skeletal system
    Das Sanjita* and Kumar Naveen Das Sanjita*,Kumar Naveen. Drug abuse and its ramifications on skeletal system. Int J Bone Marrow Res. 2019: doi: 10.29328/journal.ijbmr.1001008; 2: 083-086
  • Serum MicroRNA-155 in Acute Graft-Versus-Host-Disease (aGVHD)
    Yvonne A Efebera*, Amy S Ruppert, Apollinaire Ngankeu, Sabrina Garman, Prasanthi Kumchala, Alan Howard, Steven M Devine, Parvathi Ranganathan and Ramiro Garzon Yvonne A Efebera*,Amy S Ruppert,Apollinaire Ngankeu,Sabrina Garman,Prasanthi Kumchala,Alan Howard,Steven M Devine,Parvathi Ranganathan,Ramiro Garzon. Serum MicroRNA-155 in Acute Graft-Versus-Host-Disease (aGVHD). Int J Bone Marrow Res. 2019: doi: 10.29328/journal.ijbmr.1001007; 2: 079-082
  • Bone marrow histology in CALR mutated thrombocythemia and myelofibrosis: Results from two cross sectional studies in 70 newly diagnosed JAK2/MPL wild type thrombocythemia patients
    Jan Jacques Michiels*, Yonggoo Kim, Myungshin Kim, Francisca Valster, Vincent Potters, Zwi Berneman, Alain Gadisseur, Wilfried Schroyens and Hendrik De Raeve Jan Jacques Michiels*,Yonggoo Kim,Myungshin Kim,Francisca Valster,Vincent Potters,Zwi Berneman,Alain Gadisseur,Wilfried Schroyens,Hendrik De Raeve. Bone marrow histology in CALR mutated thrombocythemia and myelofibrosis: Results from two cross sectional studies in 70 newly diagnosed JAK2/MPL wild type thrombocythemia patients. Int J Bone Marrow Res. 2019: doi: 10.29328/journal.ijbmr.1001006; 2: 064-078
  • The forgotten player in the surgical history
    Yves Cirotteau* Yves Cirotteau*. The forgotten player in the surgical history. Int J Bone Marrow Res. 2019: doi: 10.29328/journal.ijbmr.1001005; 2: 051-063

Read More

Most Viewed

Read More

Help ?